The data suggest that N-MYC binds to the CRBN promoter region, although with weaker enrichment compared to its well-established target gene, EIF4EBP1. ASCL1 binding peak was also observed at the CRBN promoter region in the ChIP-seq dataset derived from DMS-53 SCLC cell line. Here, MYCN is linked to small cell lung carcinoma.